Page last updated: 2024-08-23

daunorubicin and Digestive System Neoplasms

daunorubicin has been researched along with Digestive System Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dupont, B; Eliaszewicz, M; Feuillie, V; Fournier, S; Gonzalez-Canali, G; Pialoux, G	1

Trials

1 trial(s) available for daunorubicin and Digestive System Neoplasms

Article	Year
Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection. Archives of dermatology, 1997, Volume: 133, Issue:7 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; CD4 Lymphocyte Count; Daunorubicin; Digestive System Neoplasms; Disease Progression; Drug Carriers; Humans; Liposomes; Lung Neoplasms; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate	1997

Article

Year

Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection.

Archives of dermatology, 1997, Volume: 133, Issue:7

Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; CD4 Lymphocyte Count; Daunorubicin; Digestive System Neoplasms; Disease Progression; Drug Carriers; Humans; Liposomes; Lung Neoplasms; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate

1997